Prognostic assays for rejection and tolerance in organ transplantation

被引:4
作者
Bradley, BA [1 ]
机构
[1] East Barn, Bristol BS32 4EF, Avon, England
关键词
organ transplantation; acute rejection; tolerance; regulation; immunosuppression; monitoring;
D O I
10.1016/j.trim.2005.03.022
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
In this review, I have summarised our understanding of acute rejection of organ transplants, and for convenience I have identified three processes, recognition, rejection and regulation. In stark contrast to this text-book picture of acute rejection, I have drawn attention to some of the clinical realities, where processes are altered by powerful immunosuppressive drugs, and where many transplant recipients are presensitised to transplantation antigens prior to engraftment. The ultimate goal is to encourage the emergence of a utopian immunological state, wherein patients tolerate organ transplants for life after being weaned from all immunosuppressive drugs. Assays that may be used in the future to reliably monitor this process are still at a very exciting stage of development. (C) 2005 Elsevier B.V All rights reserved.
引用
收藏
页码:193 / 201
页数:9
相关论文
共 71 条
[11]   Towards clinical transplantation tolerance [J].
Claas, FHJ .
LANCET, 2003, 361 (9368) :1489-1490
[12]   Tailoring of immunosuppression in renal and liver allograft recipients displaying donor specific T-suppressor cells [J].
Cortesini, R ;
Renna-Molajoni, E ;
Cinti, P ;
Pretagostini, R ;
Ho, E ;
Rossi, P ;
Cortesini, NSF .
HUMAN IMMUNOLOGY, 2002, 63 (11) :1010-1018
[13]   Decreased donor-specific cytotoxic T cell precursor frequencies one year after clinical lung transplantation do not reflect transplantation tolerance: A comparison of lung transplant recipients with or without bronchiolitis obliterans syndrome [J].
de Haan, A ;
van der Gun, I ;
Hepkema, BG ;
de Boer, WJ ;
van der Bij, W ;
de Leij, LFMH ;
Prop, J .
TRANSPLANTATION, 2000, 69 (07) :1434-1439
[14]   Chemokine and chemokine receptor gene expression indicates acute rejection of human cardiac transplants [J].
Fahmy, NM ;
Yamani, MH ;
Starling, RC ;
Ratliff, NB ;
Young, JB ;
McCarthy, PM ;
Feng, JY ;
Novick, AC ;
Fairchild, RL .
TRANSPLANTATION, 2003, 75 (01) :72-78
[15]   Relationship of donor-specific class-I anti-HLA antibodies detected by ELISA after kidney transplantation on the development of acute rejection and graft survival [J].
Fernández-Fresnedo, G ;
Pastor, JM ;
López-Hoyos, M ;
Ruiz, JC ;
Zubimendi, JA ;
Gonzalez-Cotorruelo, J ;
Rodrigo, E ;
De Francisco, ALM ;
Arias, M .
NEPHROLOGY DIALYSIS TRANSPLANTATION, 2003, 18 (05) :990-995
[16]   HLA-specific antibodies are associated with high-grade and persistent-recurrent lung allograft acute rejection [J].
Girnita, AL ;
McCurry, KR ;
Iacono, AT ;
Duquesnoy, R ;
Corcoran, TE ;
Awad, M ;
Spichty, KJ ;
Yousem, SA ;
Burckart, G ;
Dauber, JH ;
Griffith, BP ;
Zeevi, A .
JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2004, 23 (10) :1135-1141
[17]   Chemokines and their receptors as markers of allograft rejection and targets for immunosuppression [J].
Hancock, WW ;
Wang, LQ ;
Ye, QR ;
Han, RX ;
Lee, I .
CURRENT OPINION IN IMMUNOLOGY, 2003, 15 (05) :479-486
[18]   Requirement of the chemokine receptor CXCR3 for acute allograft rejection [J].
Hancock, WW ;
Lu, B ;
Gao, W ;
Csizmadia, V ;
Faia, K ;
King, JA ;
Smiley, ST ;
Ling, M ;
Gerard, NP ;
Gerard, C .
JOURNAL OF EXPERIMENTAL MEDICINE, 2000, 192 (10) :1515-1519
[19]   Immunologic monitoring [J].
Hernandez-Fuentes, MP ;
Warrens, AN ;
Lechler, RI .
IMMUNOLOGICAL REVIEWS, 2003, 196 (01) :247-264
[20]  
Hidalgo LG, 2002, CRIT REV IMMUNOL, V22, P317